FAMILIAL MEDULLARY-THYROID CANCER AND PROMINENT CORNEAL NERVES - CLINICAL AND GENETIC-ANALYSIS

Citation
La. Kane et al., FAMILIAL MEDULLARY-THYROID CANCER AND PROMINENT CORNEAL NERVES - CLINICAL AND GENETIC-ANALYSIS, The Journal of clinical endocrinology and metabolism, 80(1), 1995, pp. 289-293
Citations number
28
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
80
Issue
1
Year of publication
1995
Pages
289 - 293
Database
ISI
SICI code
0021-972X(1995)80:1<289:FMCAPC>2.0.ZU;2-O
Abstract
A unique kindred manifesting medullary thyroid carcinoma and corneal n erve thickening without other aspects of the multiple endocrine neopla sia syndrome (MEN) was analyzed by linkage analysis using four highly polymorphic (CA)(n) repeat markers (sTCL-1, D10S141, ZNF22, and sJRH-1 ). Additionally, the RET protooncogene was examined for specific mutat ions by DNA sequence analyses in all affected family members. Screenin g of 11 family members spanning 4 generations revealed 7 subjects with corneal nerve thickening; of these subjects, 3 had abnormal pentagast rin-stimulated calcitonin studies, and these 3 subjects were each foun d to have C-cell hyperplasia or medullary thyroid carcinoma at surgery . Linkage analysis showed cosegregation of alleles (as defined by the above markers), with the presence of both corneal nerve thickening and medullary thyroid carcinoma/C-cell hyperplasia (maximum LOD score, 2. 69; consistent with, but not proving Linkage). DNA sequence analysis s howed that none of the affected individuals had mutations in either ex on 10 or 11, or in exon 16 of the RET protooncogene, regions where mut ations have been described for MEN type 2A (MEN-2A) and MEN-SB familie s, respectively. Thus, compared to the defined syndromes of MEN-2A and MEN-2B, this kindred appears to represent a true clinical overlap syn drome whose genetic basis may be distinct fi om these two syndromes.